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Mechanisms for Nonrecurrent Genomic Rearrangements
Associated with CMT1A or HNPP:
Rare CNVs as a Cause for Missing Heritability
Feng Zhang,1,2 Pavel Seeman,3 Pengfei Liu,1 Marian A.J. Weterman,4 Claudia Gonzaga-Jauregui,1
Charles F. Towne,5 Sat Dev Batish,5 Els De Vriendt,6 Peter De Jonghe,6 Bernd Rautenstrauss,7,8
Klaus-Henning Krause,8 Mehrdad Khajavi,1 Jan Posadka,3 Antoon Vandenberghe,9 Francesc Palau,10
Lionel Van Maldergem,11 Frank Baas,4 Vincent Timmerman,6 and James R. Lupski1,12,13,*
Genomic rearrangements involving the peripheral myelin protein gene (PMP22) in human chromosome 17p12 are associated with
neuropathy: duplications cause Charcot-Marie-Tooth disease type 1A (CMT1A), whereas deletions lead to hereditary neuropathy with
liability to pressure palsies (HNPP). Our previous studies showed that >99% of these rearrangements are recurrent and mediated by
nonallelic homologous recombination (NAHR). Rare copy number variations (CNVs) generated by nonrecurrent rearrangements also
exist in 17p12, but their underlying mechanisms are not well understood. We investigated 21 subjects with rare CNVs associated
with CMT1A or HNPP by oligonucleotide-based comparative genomic hybridization microarrays and breakpoint sequence analyses,
and we identiﬁed 17 unique CNVs, including two genomic deletions, ten genomic duplications, two complex rearrangements, and three
small exonic deletions. Each of these CNVs includes either the entire PMP22 gene, or exon(s) only, or ultraconserved potential regulatory
sequences upstream of PMP22, further supporting the contention that PMP22 is the critical gene mediating the neuropathy phenotypes
associated with 17p12 rearrangements. Breakpoint sequence analysis reveals that, different from the predominant NAHRmechanism in
recurrent rearrangement, variousmolecularmechanisms, including nonhomologous end joining,Alu-Alu-mediated recombination, and
replication-based mechanisms (e.g., FoSTeS and/or MMBIR), can generate nonrecurrent 17p12 rearrangements associated with neuro-
pathy. We document a multitude of ways in which gene function can be altered by CNVs. Given the characteristics, including small
size, structural complexity, and location outside of coding regions, of selected rare CNVs, their identiﬁcation remains a challenge for
genome analysis. Rare CNVs may potentially represent an important portion of ‘‘missing heritability’’ for human diseases.Introduction
Genomic disorders are the pathologic conditions caused
by rearrangements of the human genome.1–3 The 17p12
rearrangement-associated neuropathy is among the
earliest identiﬁed genomic disorders: 17p12 duplications
can lead to Charcot-Marie-Tooth disease type 1A (CMT1A
[MIM 118220]) whereas deletions can lead to hereditary
neuropathy with liability to pressure palsies (HNPP [MIM
162500]).4–7 The CMT1A neuropathy phenotype is caused
by a gene dosage effect.8
Genomic rearrangements can be categorized into two
major groups: recurrent and nonrecurrent rearrange-
ments.9 Nonallelic homologous recombination (NAHR)
between paralogous sequence repeats is the predominant
mechanism underlying recurrent rearrangements with
clustered breakpoints, whereas various mechanisms or
models are implicated in nonrecurrent rearrangements
with variable breakpoints.2,9 Notably, a previous study
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meiosis, i.e., germline events.10
The recurrent 17p12 rearrangements associated with
CMT1A or HNPP are generated by NAHR events between
two low-copy repeats (LCRs), alternatively termed
segmental duplications (SDs),11 speciﬁcally involving
paralogous distal and proximal CMT1A-REP copies as
homologous recombination substrates (Figure 1).12–14
The common region affected by recurrent 17p12 rear-
rangements is ~1.4 Mb in length (Figure 1), and copy
number variation (CNV) of the PMP22 (peripheral myelin
protein 22 [MIM 601097]) gene that maps within this
genomic interval is responsible for the CMT1A and
HNPP neuropathy phenotypes. This contention is sup-
ported by the studies of both point mutations and altered
gene dosage of PMP22.7,15–19
It has been shown that most (>99%) of the CMT1A-
or HNPP-associated rearrangements in 17p12 are
recurrent and mediated by NAHR.20 However, the role of
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Figure 1. Oligonucleotide aCGH Analysis of Simple Nonrecur-
rent Genomic Rearrangements of 17p12 Associated with
CMT1A or HNPP
Above, for reference, is a horizontal line showing the 1.4 Mb
common CMT1A- or HNPP-associated rearrangement region and
its ﬂanking sequences on human chromosome 17 with cytoge-
netic bands depicted above and Megabase (Mb) genomic coordi-
nates (NCBI build 36) below. Locations of the PMP22 gene, the
distal and proximal CMT1A-REPs, and LCR17pA are shown. The
black horizontal bar shows the location and size of common re-
current 17p12 rearrangements (both deletion and duplication)
The Amethe rearrangement mechanism(s) for such nonrecurrent
rearrangements, have not been extensively investigated
and are therefore not well understood.
To study the underlying mechanism(s) for 17p12 rear-
rangements and the critical gene(s) for the neuropathy
phenotypes, we investigated 21 subjects with either
CMT1A or HNPP neuropathy that were shown by previous
assays to have apparent rare CNVs of atypical size in
17p12. We examined these genomic rearrangements by
high-density oligonucleotide-based array comparative
genomic hybridization (aCGH) and breakpoint sequence
analyses. Our observations suggest that various mecha-
nisms, including nonhomologous end joining (NHEJ),
Alu-Alu-mediated recombination, and the newly proposed
replication-based mechanisms, are involved in the
CMT1A- or HNPP-associated nonrecurrent rearrange-
ments. Furthermore, the studies conﬁrm that PMP22, by
either altered dosage or dysregulation, is the major gene
responsible for the neuropathy phenotypes of CMT1A
and HNPP. These studies document the multitude of struc-
tural changes that can alter gene function. Our ﬁndings
implicate rare CNV in both Mendelian traits and sporadic
diseases as well as being potentially responsible for some
fraction of the missing heritability of apparent complex
traits.Subjects and Methods
Subjects
Twenty-one nonrecurrent rearrangements of 17p12 associated
with CMT1A or HNPP were studied and summarized together
with another nine nonrecurrent 17p12 rearrangements that we
recently published.20 The subjects were initially screened by the
following conventional assays:20–24 multiplex ligation-dependent
probe ampliﬁcation (MLPA): A23, A26, A29, B1369; restriction
fragment length polymorphism (RFLP) genotyping with probes
showing the recombination hotspots: B70, B89, B273.1, B273.2;
microsatellite genotyping and MLPA: C1292, C2405, C2934,
C3011, C3078, C3159, C4316; and Southern blot and MLPA:
SPR1, SPR2, SP54C, SP951, SD11, SD14. Samples from CMT1A or
HNPP subjects were obtained with informed consent approved
by the Institutional Review Board for Human Subject Research at
Baylor College of Medicine and/or collaborative institutions.
Anonymous genomic DNAs (A23, A26, and A29) were provided
by Athena Diagnostics (Worcester, MA). The female control DNA
(NA15510) was obtained from Coriell Cell Repositories.associated with CMT1A or HNPP. To the left are laboratory iden-
tiﬁcation numbers of the subjects with nonrecurrent 17p12 rear-
rangements. The green (loss), black (no change), and red (gain)
dots show the relative intensities (deviation from the horizontal
line of log2Ratio ¼ zero) and genomic locations of the oligonucle-
otide probes employed in our aCGH assay. The regions that lack
unique probes correspond to the LCRs. The regions with copy
number gains are indicated in red horizontal bars, and the losses
are shown in green. Related subjects: deletions B273.1 and B273.2;
duplications C3159 andC4316. The blue vertical lines indicate the
location of the PMP22 gene. The arrow indicates the copy number
change caused by known polymorphism in the control DNA
(NA15510).
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Oligonucleotide-Based aCGH Analysis
We designed high-density oligonucleotide-based microarrays for
a comparative genomic hybridization assay to ﬁnely examine
the location, size, genomic content, and breakpoint interval of
the 17p12 rearrangements associated with CMT1A or HNPP. This
array is based on the Agilent 8 3 15K format. Approximately
15,000 oligonucleotide probes were selected from the Agilent eAr-
ray system to interrogate the 1.4 Mb common CMT1A or HNPP re-
arrangement region and its 1 Mb ﬂanking regions with a genome
resolution of ~300 bp. In subject C3011 whose rearrangement
extends outside the array coverage of the 8 3 15K array, another
4 3 44K custom-designed CGH array covering the short arm of
the human chromosome 17 was employed.20 Probes having
sequences complementary to more than one genomic locus
have been purged and only unique sequence probes were em-
ployed. After digestion with AluI and RsaI, the test DNAs were
labeled with Cy5-dCTP and control DNA was labeled with Cy3-
dCTP by means of the BioPrime Array CGH genomic labeling kit
(Invitrogen Corporation, Carlsbad, CA). Puriﬁcation of labeling
products, array hybridization, washing, scanning, and data anal-
ysis were conducted by following the Agilent oligonucleotide
aCGH protocol (version 5.0).Long-Range PCR Ampliﬁcation
The oligonucleotide aCGH data were used to initially pinpoint
approximate breakpoint positions in the genome. We next de-
signed outward-facing primers for presumed tandem duplications
and used inward-facing primers for deletions to amplify rearrange-
ment breakpoint junction.25 Different orientations and combina-
tions of primers were also tested for breakpoint analyses consid-
ering the potential for complex rearrangements. Long-range PCR
was conducted with TaKaRa LATaq polymerase. A 50 ml PCR reac-
tion was performed with 2.5 U TaKaRa LA Taq polymerase with
1 3 PCR buffer, 0.4 mM dNTP, 10 pmol of each primer, 1 ml
DMSO, and 200 ng DNA template. The PCR conditions were as
follows: 98C for 30 s, 32 cycles at 94C for 1 min, 65C for 20 s,
and 68C for 20 min, followed by 68C for 10 min.Breakpoint Sequence Analysis
PCR products that potentially contained breakpoint junctions
were submitted to SeqWright DNA Technology Services (Houston,
TX) for sequencing by the Sanger dideoxy method. DNA
sequences were analyzed by comparing to the human genome
reference assembly (NCBI Build 36) with the BLAT tool from the
UCSC Genome Browser.Results
Twenty-one subjects with CMT1A or HNPP were initially
found to have rare CNVs of atypical size in 17p12 by mi-
crosatellite genotyping, MLPA, RFLP, and/or Southern
blot. These conventional assays are both locus-speciﬁc
and ‘‘low-resolution’’ genome analysis tools for assessing
CNVs. We employed high-density oligonucleotide-based
aCGH for copy number determination and long-range
PCR ampliﬁcation for breakpoint determination and
subsequent sequence analysis in this study to comprehen-
sively examine the ‘‘genomotype’’ (i.e., location, size,
genomic content, and simple or complex type of genomic894 The American Journal of Human Genetics 86, 892–903, June 11,rearrangement)26 and breakpoint interval of the nonrecur-
rent 17p12 rearrangements associated with CMT1A or
HNPP.
Genomic Deletion Rearrangements Involving PMP22
Three simple genomic deletions, two of which are from
related subjects, were identiﬁed in this study (Figure 1).
The deletion rearrangement in subject A26 is 536 kb in
length, and the proximal breakpoint maps within the
PMP22 gene. Therefore, only the 30 end portion of
PMP22, including coding exons 4 and 5, was deleted.
Some genome rearrangements can have microhomologies
at breakpoints, i.e., one or more nucleotides shared
between distal and proximal reference sequences at the re-
arrangement ends.9 However, no microhomology was de-
tected at the breakpoint sequence of A26 (Figure S1 avail-
able online). As expected, the remaining two deletions in
related subjects B273.1 and B273.2 (father and daughter)
are the same. The 17p12 deletion in the B273 family
is ~320 kb, which includes the entire PMP22 gene. We
surmise that B273.1 transmitted the deletion to B273.2.
Breakpoint interval ampliﬁcation was not achieved and
no breakpoint sequence is available for the deletion in
the B273 family. Because the rearrangement breakpoints
in subjects B273.1 and B273.2 are apparently located
outside LCR regions, as evidenced by a transition from
normal copy to a loss relative to the control (i.e., a deletion
CNV; Figure 1), a LCR-associated failure of speciﬁc ampliﬁ-
cation can probably be excluded. However, aCGH provides
neither orientation nor genome positional information
of DNA segments in the investigated genomic rearrange-
ments. Considering that our long-range PCR assay can
amplify DNA segments up to 15–20 kb in size, we hypoth-
esize that a large insertion at the deletion breakpoint, or
other complex rearrangement that is not resolvable in the
aCGH assay, were potential causes precluding our ability
to capture the breakpoint by PCR ampliﬁcation of the
perceived breakpoint interval in B273.1 and B273.2.
Genomic Duplication Rearrangements Involving
PMP22
Eight unique genomic duplications, varying from ~400 to
1048 kb in length, were found to have increased copy
number of the entire PMP22 gene (Figure 1). Related
subjects C3159 and C4316 are brothers. The aCGH anal-
ysis showed that the duplications in C3159 and C4316
were the same. Therefore, we hypothesized that this dupli-
cation was inherited from one of their parents. However,
no parental DNA sample is available for further study of
parental origin. Breakpoint sequence analysis showed
that both distal and proximal breakpoints of this duplica-
tion map within AluY elements (Figure S1).
Interestingly, six out of the remaining seven 17p12
duplications (B70, B89, B1369, C2934, C3078, and
SP54C) have proximal breakpoints in LCRs, i.e., LCR17pA
or proximal CMT1A-REP (Figure 1),27 whereas their distal
breakpoints are in unique genomic regions. Therefore, it2010
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Figure 2. CMT1A-Associated 17p12 Duplications Exclusive of the PMP22 Coding Region but Involving the Potential Upstream Regu-
latory Sequence
(A) Two duplications (red bars) of the upstream region of PMP22were identiﬁed in subject SPR1 and related subjects SD11 and SD14. The
SRO involves the TEKT3 and CDRT4 genes, whereas PMP22 is intact and has normal copy number. Both the noncoding exons (1A and
1B) and coding exons (2 to 5) are shown. Three ultra CNSs associated with conserved human transcription factor binding sites were
present in SRO.
(B) The information of CNS size, lod score, and transcription factor binding site was provided. Details are provided in Figures S2 and S3.can be challenging to amplify the speciﬁc breakpoint inter-
vals in these subjects because of the inability to uniquely
identify a speciﬁc genomic location for a PCR assay.
Long-range PCR ampliﬁcation was achieved only in
subject SP54C and the breakpoint sequencing data re-
vealed a recombination event between two AluSg elements
(Figure S1).
In subject SP951, sequence complexity was identiﬁed in
breakpoint sequence analysis (Figure S1). A 23 bp frag-
ment (TAAAATTATCTTTTAGTCATTAA) was inserted at
the join point between the distal and proximal break-
points. This insertion can be copied from the DNA
template that is only a few nucleotides adjacent to the
distal breakpoint. These ﬁndings suggest the potential
involvement of the serial replication slippage (SRS) mech-
anism in generating the complex duplication in
SP951.28,29 Alternatively, the sequence complexity is also
consistent with multiple NHEJ events. The enzymatic
features of both replication slippage and NHEJ mecha-
nisms underlying genomic rearrangements have been
summarized by Lieber (2010).30
Genomic Duplication Involving Only the Sequences
Upstream of PMP22
In addition to the genomic rearrangements inclusive of
PMP22, it was recently reported that a genomic duplication
affecting only the upstream region of PMP22 can also lead
to CMT1A potentially by altering the PMP22 gene expres-
sion.24 Two previously reported subjects (SD11 and
SD14) with this 186 kb duplication24 were also studied
by oligonucleotide-based aCGH in this study and the rare
CNV was conﬁrmed. This duplication CNV affects only
the upstream sequence with one breakpoint mapping
~34 kb proximal to the PMP22 gene (Figure 2).24 A 1 bpmi-
crohomology was identiﬁed at the breakpoint (Figure S1).The AmeThe other CMT1A-associated duplication devoid of the
PMP22 coding region was newly identiﬁed in subject
SPR1 to be 194 kb in length with one breakpoint only
~9 kb proximal to the PMP22 gene (Figure 2). The break-
point sequence analysis showed a 5 bp microhomology
(TCTCT) at the junctions (Figure S1).
It has been hypothesized that the CMT1A-associated
duplications exclusive of the PMP22 coding region may
affect a conserved region upstream of PMP22 and
potentially cause dysregulation of PMP22 gene expres-
sion.24 The above two different duplications share a 168
kb smallest region of overlap (SRO; chr17:15,143,663-
15,311,619, NCBI build 36) with one end that is located
only 34 kb proximal to the PMP22 gene. Several highly
conserved noncoding sequences (CNSs) are located within
this duplication SRO interval (Figure 2; Figure S2). These
observations support the potential involvement of altered
dosage or CNV of the regulatory regions for PMP22 in the
CMT1A-associated duplications exclusive of PMP22 coding
sequences.
Clinical Findings in PMP22 Upstream Duplication
CNVs
No differentiating clinical features were observed speciﬁc
to the CMT subjects with PMP22 upstream duplications.
However, their clinical phenotypes, although variable
between individuals, appear milder than those usually
mediated by PMP22 gene duplications.
As for the 186 kb PMP22 upstream duplication previ-
ously identiﬁed in multiple unrelated families (including
subjects SD11 and SD14 in this study), the phenotype is
variable between and within affected families.24 However,
milder phenotypes than those in classic CMT1A caused
by PMP22 duplications were observed in most cases,
including relatively late age of onset, normal to briskrican Journal of Human Genetics 86, 892–903, June 11, 2010 895
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LCR17pAreﬂexes, and mildly reduced nerve conduction velocities
(NCVs).24
A relatively mild phenotype was also observed in subject
SPR1 that was newly identiﬁed in this study to have
a 194 kb PMP22 upstream duplication CNV. Motor NCVs
of upper and lower extremities were mildly reduced
(median nerve right 44.5 m/s, ulnar nerve right 44 m/s,
peroneal nerve right 30 m/s).C2405
FoSTeS
del dup
1
2
C3011
(8x15K)
B CMT1AREP
CMT1A
REP
SMS
REP
SMS
REP
LCR17pA
C3011
(4x44K)
Rearrangement 1: dup-nml-dup-nml-dup
distal and middle SMS-REPs
mediated NAHR
Rearrangement 2: dup-nml-dup
Inversion
Figure 3. Oligonucleotide aCGH Analysis Revealed Complex
Genomic Rearrangements in 17p12
(A) Subjects C1292 and C2405 are related (C2405 is the sister of
C1292’s maternal grandfather). Two proposed FoSTeS events
(FoSTeS 3 2) consistent with this complex rearrangement were
shown.
(B) In C3011, the 17p CGH array (4 3 44k format) revealed addi-
tional duplications in 17p11.2 that is not covered by the CMT1A
array (8 3 15k format). Rearrangement abbreviations: nml,
normal; dup, duplication. This complex rearrangement can beComplex Rearrangements Involving PMP22
In addition to the simple types (either duplication or dele-
tion) of nonrecurrent 17p12 rearrangements, we also iden-
tiﬁed three subjects with CMT1A-associated complex
genomic rearrangements involving the entire PMP22
gene (Figure 3). Subjects C1292 and C2405 are related;
C2405 is the sister of C1292’s maternal grandfather.
High-density aCGH analysis revealed a 1294 kb complex
rearrangement in 17p12with aCGHdata showing a pattern
consistent with deletion-normal-duplication wherein the
entire PMP22 gene was duplicated (Figure 3). Breakpoint
sequence analysis showed an AluY-AluY-mediated recom-
bination between the distal end of the deletion and the
proximal end of the duplication, whereas a 22 bp insertion
of unknown origin was identiﬁed at the breakpoint
interval between the distal end of duplication and the
proximal end of deletion (Figure S1).
The genomic rearrangement in subject C3011 is the
largest one among the 17 unique CMT1A or HNPP rear-
rangements. The proximal end of the genomic rearrange-
ment in C3011 extended outside the coverage of our 8 3
15K CGH microarray interrogating the 1.4 Mb common
17p12 rearrangement region and its ﬂanking sequences
(1 Mb on each side; Figure 3). Therefore, a 4 3 44K CGH
array covering the entire short arm of the human chromo-
some 17 was used to re-examine the genomic rearrange-
ment in C3011. Interestingly, two additional segments
with copy number gains were identiﬁed. These observa-
tions indicated a complex rearrangement of ~3.4 Mb in
C3011 (Figure 3). Ampliﬁcation of potential breakpoint
intervals was achieved only between the distal and prox-
imal ends of the small duplication from 17.73 to
17.86 Mb on the human chromosome 17 (NCBI build 36)
and a 23 bp insertion of unknown origin was identiﬁed at
the breakpoints (Figure S1).
alternatively interpreted as duplication-normal-duplication-
normal-duplication or duplication-normal-duplication that is
accompanied by an inversion polymorphism mediated by NAHR
between two inverted LCRs (distal and proximal SMS-REPs).Exonic Rearrangements Deleting One or Several
Exons of PMP22
Three exonic deletions were identiﬁed by our high-density
aCGH analysis. The 5 kb deletion in subject A23 and the
13 kb deletion in subject A29 affect the coding exons 2
and 3 of PMP22, whereas the 17 kb deletion in subject
SPR2 involves only the PMP22 exon 4 (Figure 4). Break-
point sequence analysis showed microhomologies at the
breakpoints of both subjects A23 (A) and A29 (TC). No mi-
crohomology was identiﬁed at the breakpoint of subject
SPR2, but instead a 3 bp short sequence (CAT) that did896 The American Journal of Human Genetics 86, 892–903, June 11,not match the reference human genome sequence was
found at the breakpoint (Figure S1).Discussion
Genomic rearrangements of 17p12 previously identiﬁed
by conventional molecular assays in 21 subjects with2010
SPR2
A29
A23
PMP22 exons5 4 32
Figure 4. Oligonucleotide aCGH Analysis of Exonic Rearrange-
ments of PMP22
The deleted regions are shadowed. Below, the locations of the
PMP22 gene and its coding exons (2 to 5) are shown. Exon 4 is
deleted in subject SPR2. Both subjects A23 and A29 have deletions
of exons 1–3.CMT1A or HNPP were newly investigated by high-resolu-
tion genome analysis with an oligonucleotide-based
aCGH assay and breakpoint sequence analysis. Together
with another nine (seven unrelated) subjects with nonre-
current 17p12 rearrangements that were recently re-
ported,20 we now summarize the observations of 24
unique rare CNVs of 17p12 in 30 subjects with neuropathy
(Table 1). All 30 subjects were ascertained by virtue of
a neuropathy phenotype. By these analyses we narrow
the critical region for CMT1A and HNPP, study the break-
point characteristics, and infer the rearrangement mecha-
nisms. We also show a multitude of ways that CNVs at
this locus can cause neuropathy, including genomotypes
that do not even include any PMP22 coding exons, i.e.,
upstream duplication CNVs.
PMP22 Is Critical for the 17p12 Rearrangement-
Associated Neuropathy Phenotypes
In the 1.4 Mb common recurrent rearrangements associ-
ated with CMT1A or HNPP, the PMP22 gene is the
dosage-sensitive gene involved in conveying the neurop-
athy phenotype. All 24 unique nonrecurrent types of
17p12 rearrangements mediate neuropathy by affecting
(1) the entire PMP22 gene (i.e., gene dosage), (2) individual
PMP22 exon(s), or (3) ultraconserved noncoding
sequences upstream of PMP22 (Figures 1–4). The SRO of
the PMP22 upstream duplications potentially reﬂects the
genomic regions important to the regulation of PMP22
gene expression (Figure 2).
Half (12 CNVs, 50%) of the 24 rare CNVs in 17p12 did
not perturb the coding sequence integrity, but instead
altered the gene copy number by deletion (two related
subjects, B273.1 and B273.2), duplication (10 unique
duplication CNVs), or even triplication (two relatedThe Amesubjects, A2 and A9) of the entire coding region of
PMP22 (Figures 1 and 3; Table 1).
Ten (42%) out of 24 rare CNVs in 17p12 are partial dele-
tions of PMP22, including subjects A23, A26, A29, and
SPR2 in this study and subjects A10, A11, A12, A14, A15,
and A21 in our previous study.20 These deletions affect
only portions of the PMP22 gene, i.e., only one or several
exons. These observations suggest that not only deletions
of the entire PMP22 gene and point mutations in PMP22,
but partial PMP22 deletions involving only one or a few
exons can also potentially result in loss-of-function muta-
tions and haploinsufﬁciency of the PMP22 protein and
cause neuropathy.
No partial duplication of PMP22 has been identiﬁed in
this study. The bias of prevalent deletion versus rare dupli-
cation for exonic PMP22 rearrangements in the subjects
with neuropathies can be potentially explained by the
argument that a portion of exonic PMP22 duplications
could be benign as indicated by the fact that these duplica-
tions do not alter PMP22 gene dosage by creating an addi-
tional complete copy of PMP22. Interestingly, a 25 kb
duplication involving PMP22 exons 4 and 5 has been
reported in the African (Yoruba) population of
HapMap.31 However, some PMP22 exonic duplications
may be pathogenic mutations through exon shufﬂing,
insertional translocation, or other molecular mecha-
nisms.32,33
Interestingly, Weterman et al.24 recently reported iden-
tical 186 kb duplications in 11 subjects from 6 seemingly
unrelated Dutch families. This duplication proximal to
but exclusive of the coding region of PMP22 can also lead
to the CMT1A phenotype that is usually associated with
copy number gain of PMP22. It was suggested by the haplo-
type study of Weterman et al.24 that the neuropathy
subjects with the 186 kb duplication share an ancestral
mutation. The breakpoint sequence analysis of this current
study showed that LCRs as NAHR substrates were absent at
the breakpoints of the 186 kb duplication; therefore, the
possibility of recurrent duplication events mediated by
NAHR can be excluded. The 186 kb duplications from
unrelated families probably have a common ancestral
origin rather than multiple independent occurrences.
In addition to this 186 kb duplication, another
duplication involving the upstream region of PMP22 was
identiﬁed during this study in subject SPR1. This 194 kb
duplication of SPR1 is located closer to PMP22 than that
found in subjects SD11 and SD14 (9 kb versus 34 kb). There
are two protein coding genes located in the SRO of the
above two duplications: TEKT3 (MIM 612683) and
CDRT4 (Figure 2). TEKT3 encodes a putative testicular
microtubule-associated protein that is primarily expressed
in male germ cells,34 whereas no molecular function has
been reported forCDRT4. Instead, both increased dosage4,8
and point mutations of PMP2215,19 have been previously
reported to cause CMT1A. Therefore, the PMP22 gene is
the most likely gene responsible for the neuropathy
phenotype in these two upstream duplications. Therican Journal of Human Genetics 86, 892–903, June 11, 2010 897
Table 1. Summary of Nonrecurrent 17p12 Rearrangements with Breakpoint Characteristics and Underlying Mechanisms in 30 Subjects
with Neuropathy
Subject Rearrangement Size (kb)
Breakpoint Characteristics
MechanismDistal Proximal Microhomology
Complex Rearrangement
C3011 dup-nml-dup-nml-dup ~3400a AluJo N.A. RBM
Alu/L2 N.A.
SMS-REP SMS-REP N.A.
C1292, C2405 del-nml-dup 1294a AluY AluY 27 bp RBM
L1 N.A.
A2,b A9b dup-tri-dup-nml-dup 520a Alu/L1 N.A. RBM
Alu/L1/L2 N.A.
LCR17pA LCR17pA N.A.
A15,b A15.2b del-nml-del-nml-dup 9a L1 AACA RBM (FoSTeS 3 3)
L1 AACCT
AAG
Duplication
C3159, C4316 dup 1048 AluY AluY 24 bp Alu-Alu/RBM
B89 dup ~590 LCR17pA N.A. N.A.
B70b dup ~500 LCR17pA N.A. N.A.
C2934 dup ~500 Alu/L1 LCR17pA N.A. N.A.
SP951 dup 437 L1 L2 none NHEJ/RBM
L1 L2 TTTA
SP54C dup 412 AluSg AluSg/LCR17pA GTTTCACCAT Alu-Alu/RBM
B1369 dup ~400 LCR17pA N.A. N.A.
C3078 dup ~400 Alu/L1 LCR17pA N.A. N.A.
SPR1 dup 194 TCTCT NHEJ/RBM
SD11, SD14 dup 186 AluSq/x A NHEJ/RBM
Deletion
A26 del 536 none NHEJ
B273.1, B273.2 del ~320 Alu/L1 N.A. N.A.
A10b del 17 AluJo GATT NHEJ/RBM
SPR2 del 17 AluJo none NHEJ
A29 del 13 TC NHEJ/RBM
A21b del 12 C NHEJ/RBM
A11b del 7 AC NHEJ/RBM
A23 del 5 A NHEJ/RBM
A12b del <1 GACG NHEJ/RBM
A14b del <1 GC NHEJ/RBM
Note: Related subjects are listed in the same line.
Abbreviations: del, deletion; nml, normal; dup, duplication, tri, triplication; NHEJ, nonhomologous end joining; RBM, replication-based mechanism; N.A., not
available.
a The sizes of the entire genomic region involved in complex rearrangements are shown.
b These subjects have been previously published.20,21 Subject A15 and her affected sister A15.2 have the same complex exonic PMP22 deletion, and their healthy
mother is mosaic (both germ line and somatic) for the identical rearrangement.20 B70 is the patient of the LF26 family published by Palau et al.21
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hypothesized dysregulation of PMP22 is supported by the
observations of three ultraconserved noncoding sequences
comprising conserved transcription factor binding sites in
the SRO (Figure 2; Figures S2 and S3).
These ﬁndings in this study and the previous report
suggest that not only PMP22 gene duplications but dupli-
cation of the adjacent genomic region upstream of the
PMP22 gene can also lead to CMT1A potentially through
altering PMP22 gene expression. Notably, in both of the
cases reported by Weterman et al.24 and the different sized
one reported herein, the duplications of upstream regula-
tory sequences conveyed a less severe phenotype than
did PMP22 gene duplications. Our observations in the
neuropathy-associated 17p12 rearrangements involving
the coding region or upstream regulatory region of the
PMP22 gene further conﬁrm that PMP22 is the critical
gene for CMT1A and HNPP. Interestingly, in another
dosage-sensitive gene (PLP1 [MIM 300401]), the gene
duplication of which causes the central nervous system
dysmyelinating disorder Pelizaeus-Merzbacher disease
(PMD [MIM 312080]), the duplication of downstream
genomic region adjacent to PLP1 is also associated with
phenotypic consequences.35 Thus, CNV either upstream
or downstream from a dosage-sensitive gene may perturb
gene regulation, perhaps through altering chromatin
structure, remodeling, or other position effects underlying
long-range control of gene expression.36
Complex Rearrangements in 17p12 and DNA
Replication-Based Mechanisms
In addition to the simple types (e.g., deletion or duplica-
tion) of nonrecurrent rearrangements, complex rearrange-
ments also exist and play an important role in genomic
disorders;25,37 for example, complex rearrangements in
17p11.2 account for 57% of the nonrecurrent rearrange-
ments associated with Potocki-Lupski syndrome (PTLS
[MIM 610883]).20 In our current study, we also identiﬁed
complexities in four subjects: C3011; two related cases,
C1292 and C2405, based on the aCGH assay (Figure 3);
and SP951, based on the breakpoint sequence analysis
(Figure S1). Taking the previously identiﬁed complex
17p12 rearrangements (related subjects A2 and A9 and
related individuals A15 and A15.2 from family
HOU1109)20 into account, a sum of at least 21% (5/24)
was identiﬁed to be complex in the rare 17p12 rearrange-
ments associated with neuropathy. For six unique aCGH-
based simple rearrangements (6/24, 25%), we could not
obtain breakpoints; therefore, potential complexities may
not have been identiﬁed at the level of resolution afforded
by aCGH.
Notably, these complex CNVs cannot readily be
explained by a simple rearrangement event mediated by
the long-established DNA recombination mechanisms,
for example, NAHR or NHEJ.2,9,38 To explain the
observations of both complexity and microhomology at
the breakpoints, we proposed a replication fork stalling
and template switching (FoSTeS) mechanism involvingThe AmeDNA replication errors in human subjects.25 Studies from
both human subjects and other model organisms
including bacteria and yeast further delineate the molec-
ular details and proposed microhomology-mediated
break-induced replication (MMBIR).39 The MMBIR mecha-
nism proposes: (1) fork stalling by a collapsed replication
fork; as the replication fork proceeds through a DNA
single-stranded nick and generates a one-ended, double-
stranded DNA, that must be processed distinctly from
a two-ended, double-stranded break that is the usual
substrate for double-stranded break repair, and (2)
template switching, as part of a break-induced replication,
resulting in microhomology at the ‘‘join point’’ reﬂecting
the priming of DNA replication on the new ‘‘template
switched’’ fork. DNA replication-based mechanisms
(RBMs) include serial replication slippage (SRS),28,29
FoSTeS, and/or MMBIR,20,25,39 microhomology/microsa-
tellite-induced replication,40 and other similar models.
The details of these mechanisms have been reviewed
recently.41,42
Microhomology, as a hallmark of RBM, can be traced at
the breakpoints of complex rearrangements. In the related
subjects C1292 and C2405, a microhomology of 27 bp
shared by two AluY elements was detected at one of their
breakpoints (Table 1; Figure S1), which was alternatively
consistent with Alu-Alu-mediated recombination43,44
and/or RBMs,26,41 though the feature of rearrangement
complexity in C1292 and C2405 is more parsimonious
with the latter. In subject SP951, sequence-based
complexity was identiﬁed at breakpoints, i.e., a 23 bp frag-
ment that can be copied from an adjacent DNA template
and inserted at the breakpoint by SRS28,29 or other RBMs
(Figure S1). However, only one microhomology of TTTA
was identiﬁed at the breakpoint of SP951 (Table 1;
Figure S1), whereas two microhomologies were expected
according to the SRS model. The potential involvement
of more complex rearrangement events cannot be
excluded; for example, multiple NHEJ processes might
generate such an event.30,41,45 Two NHEJ events having
no microhomology at the ﬁrst breakpoint and a microho-
mology of TTTA at the second breakpoint can potentially
cause the sequence complexity in SP951 (Figure S1).
Various Mechanisms Involved in Nonrecurrent
Rearrangements of 17p12
Distinct from one predominant NAHR mechanism in
recurrent rearrangements, various mechanisms have been
implicated in nonrecurrent rearrangements: NHEJ, Alu-
Alu-mediated recombination, and RBMs have been shown
to be involved in the nonrecurrent rearrangements in
17p12.
In the NHEJ events, an ‘‘information scar’’ of cleavage
or addition of several nucleotides from or to the ends
of double-strand break can be left at breakpoints,9,38
which are characteristic and can help distinguish the
NHEJ-mediated rearrangements from the rearrangement
products of other mechanisms. In this study, norican Journal of Human Genetics 86, 892–903, June 11, 2010 899
Table 2. Prevalence of Repeat and Repetitive Sequences at
Breakpoints of 24 Unique Nonrecurrent Rearrangements in 17p12
Rearrangement Type Number
No. (%) of Breakpoints in
Repeat or Repetitive Sequences
Distal Proximal
(1) Nonrecurrent Rearrangements of 17p12
Deletion 2 0 (0%) 1 (50%)
Duplication 10 5 (50%) 9 (90%)
Complex 3 3 (100%) 3 (100%)
All 15 8 (53%) 13 (87%)
(2) Exonic Rearrangement of PMP22
Deletion 8 2 (25%) 0 (0%)
Complex 1 0 (0%) 1 (100%)
All 9 2 (22%) 1 (11%)
The percentages >50% are shown in bold.microhomology is identiﬁed at the breakpoints of subjects
A26 and SPR2. Instead, a 3 bp mismatched sequence (CAT)
was identiﬁed at the breakpoint of SPR2. These observa-
tions, consistent with the nucleotide addition or cleavage,
suggest that the NHEJ mechanism generated the nonrecur-
rent rearrangements in these two subjects.
Alu-Alu-mediated recombination is another mechanism
for nonrecurrent rearrangement.43,44 Different from previ-
ously reported uncommon NHEJ events that join two Alu
elements together and generate a longer fused breakpoint
sequence,46 Alu-Alu-mediated recombination can cause
a recombinant Alu with microhomology shared by two
repetitive Alu elements. In related subjects C3159 and
C4316, the breakpoint interval was mediated between
two AluY elements, wherein a 24 bp microhomology was
shared (Figure S1). In subject SP54C, the breakpoints are
mediated between two AluSg elements, which shared
a 10 bp microhomology (Figure S1). These above two
nonrecurrent rearrangements are apparently consistent
with an Alu-Alu-mediated recombination mechanism.
However, considering the microhomologies that were
identiﬁed at breakpoints, the involvement of RBMs (e.g.,
DNA template switching for only one time in the FoSTeS
event resulting in a deletion or a duplication)20 cannot
be excluded.
In ﬁve subjects (A23, A29, SPR1, SD11, and SD14) with
nonrecurrent rearrangements, microhomologies of 1 to 5
bp were identiﬁed at breakpoints, which can alternatively
be explained by either NHEJ or RBMs.Prevalence of Repeat and Repetitive Sequences at
Breakpoints of Nonrecurrent 17p12 Rearrangements
Distinct from the location of recurrent rearrangement
breakpoints clustering in LCRs,9 no such restriction
has been reported for the breakpoints of nonrecurrent
rearrangements. However, the presence of both repeat900 The American Journal of Human Genetics 86, 892–903, June 11,and repetitive sequences at breakpoint junctions and the
proximity of complex LCRs to breakpoint grouping have
been reported in nonrecurrent duplications of MECP2,
RAI1, and many other loci.27,37,47 Similarly, the prevalence
of repeats (i.e., LCRs or SDs) and repetitive sequences
(including long interspersed elements [LINEs] and short
interspersed elements [SINEs]) was observed in the neurop-
athy-associated genomic rearrangements of this study,
especially in the genomic duplications and complex rear-
rangements (Tables 1 and 2).
We identiﬁed 24 unique CNVs in the 30 neuropathy-
associated nonrecurrent rearrangements summarized in
this study, including 15 large genomic rearrangements of
17p12 and 9 exonic rearrangements of the PMP22 gene.
The statistics of the breakpoints located in repetitive or
repeat sequences are shown in Table 2. Interestingly, the
prevalence of SINEs (e.g., Alu families), LINEs (e.g., L1
and L2), and LCRs (also rich in SINEs and LINEs) was
observed in the breakpoints of large genomic rearrange-
ments of 17p12, especially those of genomic duplications
(distal, 50%; proximal 90%) and at least one breakpoint
of each complex rearrangement (both distal and proximal,
100%) (Table 2), which is much higher than the composi-
tion of ~34% for LINEs and SINEs in the human genome.48
Notably, 7 (54%) out of these 10 genomic duplications and
3 complex rearrangements of 17p12 have proximal
breakpoints in LCR17pA. This ﬁnding is consistent with
evolutionary studies of the proximal 17p region in
primates, suggesting that LCRs or SDs acted as the seeds
of serial segmental duplication events and led to more
complex genomic architecture in 17p.49,50 This ﬁnding is
also consistent with the observed breakpoint grouping of
nonrecurrent rearrangements seen at other genomic
disorder loci, such as PLP1 and MECP2.25,37
These observations reﬂect the special genomic
architecture prone to genome instability. Because the
repetitive sequences have been found to be associated
with double-strand breaks or stalled replication, subse-
quent DNA repair via NHEJ or restarting DNA replication
by template switching can be involved and lead to
genomic rearrangements.51–53
The prevalence of repeats or repetitive sequences is not
obvious at the breakpoints of small exonic PMP22 rear-
rangements (Table 2). This phenomenon is possibly due
to the below-average content of SINEs and LINEs in the
PMP22 gene region (24% in PMP22 versus genome-wide
34%).
Missing Heritability
Although tremendous efforts have been expended to
dissect the genetic factors underlying human diseases,
the genetic code accounts for only <20% of the known
disease-associated variations in the human genome.54
The genetic variation observed is only as good as the
method used to detect it. Many of the variants described
to be small, complex, and/or exclusive of gene coding
regions in the present study are challenging and may not2010
be detected by currently implemented clinical assays for
the CMT1A duplication and HNPP deletion. Rare CNVs
caused by genomic rearrangements can be one source of
variation potentially responsible for the ‘‘missing herita-
bility’’ of human diseases.
In our previous studies,26 we introduced a new concept
of genomotype (different from the traditional genotype)
to describe CNVs of genomic segments and the study of
such variations or changes in the context of genomic
disorder phenotypes to determine genomotype-pheno-
type correlations as a way to unravel the genomic code.
In this study, we also showed how genomic alterations,
such as deletion, duplications, and complex rearrange-
ments involving exons, noncoding upstream sequences,
the entire PMP22 gene, or together with the ﬂanking
genomic regions, can lead to the neuropathy phenotypes
of CMT1A and HNPP. Our study of rare CNVs with
different sizes and genomic content in 17p12 further
dissected the heritability associated with the neuropathy
phenotype that is usually manifested by the 1.4 Mb
common CNV in 17p12. Genomotype-phenotype correla-
tions will be particularly relevant to the elucidation of the
genomic code, especially in the instances where the CNV
does not involve coding sequences, because coding
sequences account for <2% of the human genome.48
In summary, our study documents that various
mechanisms, including NHEJ, Alu-Alu-mediated recombi-
nation, and RBMs (e.g., SRS, FoSTeS, and/or MMBIR), are
implicated in the nonrecurrent 17p12 rearrangements
associated with neuropathy phenotypes. We also further
document that rare CNVs, even those exclusive of coding
sequences, can cause human diseases and suggest that
CNVs that do not either involve genes or include coding
sequences can nevertheless effect gene regulation. We
speculate that CNVs involving both coding and noncod-
ing sequences may be a type of variation responsible for
some fraction of missing heritability.
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